Identification of Circulating MiR-4651 as Novel Biomarker for Metabolic Dysfunction-Associated Steatotic Liver DiseaseCirculating MiR-4651作为代谢功能障碍相关脂肪性肝病新型生物标志物的鉴定Gastro Hep AdvancesIF02025-12-010OAAI
Altered profiles of circulating cytokines in chronic liver diseases (NAFLD/HCC): Impact of the PNPLA3I148M risk alleleHEPATOLOGY COMMUNICATIONSIF4.62023-12-014OAAI
Modulation of the IL-6-Signaling Pathway in Liver Cells by miRNAs Targeting gp 130, JAK1, and/or STAT3MOLECULAR THERAPY-NUCLEIC ACIDSIF02019-06-0131OAAI
Cytokine-mediated modulation of the hepatic miRNome: miR-146b-5p is an IL-6-inducible miRNA with multiple targetsJOURNAL OF LEUKOCYTE BIOLOGYIF3.12018-08-2619OAAI
The PD-L1-and IL6-mediated dampening of the IL27/STAT1 anticancer responses are prevented by α-PD-L1 or α-IL6 antibodiesJOURNAL OF LEUKOCYTE BIOLOGYIF3.12018-07-2413OAAI
Role of microRNAs in signal transduction pathways of the inflammatory cytokine interleukin-6 in hepatocellular carcinoma cell lines and primary hepatocytesEUROPEAN JOURNAL OF CANCERIF7.12016-07-010PREAI
Role of microRNAs in signal transduction pathways of the inflammatory cytokine Interleukin-6: Relevance for liver diseasesCYTOKINEIF3.72015-11-010OAAI